This is an ASCO Meeting Abstract from the 2021 ASCO Annual Meeting I. This abstract does not include a full text component.
Panitumumab+best supportive care (BSC) significantly improved progression-free survival (PFS) vs BSC alone in patients with chemo-refractory wild-type KRAS metastatic colorectal cancer (mCRC). We ...
Avelumab plus BSC significantly improved OS and PFS in advanced urothelial carcinoma patients, irrespective of diabetes status, as shown in the JAVELIN Bladder 100 trial. The trial's findings led to ...
You deserve a positive teaching and learning experience, where you feel part of a supportive and nurturing community. That’s why most students will enjoy an innovative approach to learning using block ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results